期刊
OPHTHALMOLOGY AND THERAPY
卷 11, 期 3, 页码 1001-1015出版社
SPRINGER INT PUBL AG
DOI: 10.1007/s40123-022-00505-y
关键词
Cataract surgery; Dry eye disease; Ocular surface disease; Ocular surface optimization; Ophthalmic surgery; Refractive surgery
资金
- Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA
Proper preoperative management of ocular surface disease is crucial in reducing inflammation, resolving infection, improving epithelial pathology, stabilizing the tear film, and promoting positive long-term outcomes after ophthalmic surgery.
Ocular surface disease commonly exists in individuals requiring ophthalmic surgery and may compromise the structure and function of ocular surface components. Ophthalmic surgery may further affect the ocular surface by injuring the epithelium and sensory nerves, disrupting the tear film, or causing local inflammation. Medical management of ocular surface disease prior to ophthalmic surgery aids in reducing inflammation, resolving infection, improving epithelial pathology, stabilizing the tear film, and easing patient symptoms, promoting positive long-term outcomes and minimizing the incidence of postoperative complications. This review summarizes frequently encountered ocular surface diseases and available preoperative medical management options, discusses common ophthalmic surgeries and their effects on the ocular surface, examines potential postoperative complications, and defines recommendations for postoperative ocular surface maintenance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据